


336 F.3d 1322
United States Court of Appeals,
Federal Circuit.
TORPHARM, INC., Plaintiff-Appellant,
v.
RANBAXY PHARMACEUTICALS, INC., Schein Pharmaceutical, Inc., Danbury Pharmacal, Inc., Ranbaxy Laboratories Limited, Ranbaxy Schein Pharma L.L.C., and Ranbaxy Schein Pharmaceuticals, L.L.C., Defendants-Appellees.
No. 02-1590.
|
July 23, 2003.
Synopsis
Owner of patent for process of making chemical used in ulcer drug sued competitor for infringement. The United States District Court for the District of New Jersey, John C. Lifland, Senior Judge, granted summary judgment of invalidity, and appeal was taken. The Court of Appeals, Clevenger, Circuit Judge, held that owner was not estopped from arguing that patent was nonobvious.
 
Reversed and remanded.
 
